Brexit Ambiguity A Top Priority For Bayer's New UK & Ireland CEO
Lars Bruening, who recently succeeded Alexander Moscho as Bayer's CEO for the UK and Ireland, talks to Scrip about Brexit uncertainties and fostering the right dialog between pharma and healthcare systems.